vaxzevria
Vaccineexperimental
Clinical trial activity
4 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started May 10, 2021 (NCT04907331)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05387317 | Phase 3 | Feb 28, 2023 | Coalition for Epidemic Preparedness Innovations, Government of Indonesia, Murdoch University, Padjadjaran University, The Peter Doherty Institute, University of Indonesia |
| NCT05534035 | Phase 3 | Feb 3, 2023 | Everest Medicines |
| NCT05188677 | Phase 3 | Jun 13, 2022 | Clover Biopharmaceuticals |
| NCT04907331 | Phase 2 | May 10, 2021 | Medical University Innsbruck, Medical University of Graz, Medical University of Vienna |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Clover Biopharmaceuticals | For profit | 1 | 1 | 1 | 2022 |
| Coalition for Epidemic Preparedness Innovations | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Everest Medicines | For profit | 1 | 1 | 1 | 2023 |
| Government of Indonesia | Government | 1 | 0 | 1 | 2023 |
| Medical University Innsbruck | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Medical University of Graz | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Medical University of Vienna | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Murdoch University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Padjadjaran University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| The Peter Doherty Institute | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Indonesia | Academic/Hospital | 1 | 0 | 1 | 2023 |
11 organizations
Page 1 / 1